CUSIP: 019621200
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,374,093
-
Share change
-
+540,570
-
Total reported value
-
$36,056,618
-
Price per share
-
$3.17
-
Number of holders
-
39
-
Value change
-
+$1,472,189
-
Number of buys
-
25
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 019621200?
CUSIP 019621200 identifies ALQA - ALLIQUA BIOMEDICAL INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 019621200:
Institutional Holders of ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) as of Q3 2015
As of 30 Sep 2015,
ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,374,093 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, DEERFIELD MANAGEMENT CO, Tekla Capital Management LLC, J. Goldman & Co LP, SENZAR ASSET MANAGEMENT, LLC, venBio Select Advisor LLC, SUFFOLK CAPITAL MANAGEMENT LLC, PURA VIDA INVESTMENTS, LLC, Healthcare Value Capital, LLC, and VANGUARD GROUP INC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.